94818 ⎘
Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups -
Sub-classes:COVALENT, CHEMOGENETIC ACTIVATORS FOR K2P POTASSIUM CHANNELS AND USES THEREOF
#2TEAD INHIBITORS
#3MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS
#4Modulators of Alpha-4-beta-7 Integrin and MAdCAM
#5Simplified structural mimetics of AIPS as quorum sensing inhibitors
#6GAS5 binding compounds, formulations, and uses thereof
#7Simplified structural mimetics of AIPS as quorum sensing inhibitors
#8CATALYSTS
#9Anthracene-based organic dyes and preparation methods thereof
#10Catalysts
#11Immunoproteasome inhibitor analogs
#12Modulators of indoleamine 2,3-dioxygenase
#13Compounds for the detection, capture and/or separation of polluting gases
#14Simplified structural mimetics of AIPS as quorum sensing inhibitors
#15Catalysts
#16Synthesis of syrbactin proteasome inhibitors
#17Cyclic carbodiimide compound, polyester film, back sheet for solar cell module, and solar cell module
#18Method for recovering precious metal from solution containing precious metal ions, extracting agent or adsorbent used therefor, and back-extracting agent or desorbent
#19Coating compositions
#20Synthesis of syrbactin proteasome inhibitors
#21PALLADIUM ION ADSORBENT AND METHODS FOR SEPARATING AND RECOVERING PALLADIUM USING IT
#22Compounds, compositions and methods for treating or preventing hypoxic or ischemic injury
#23MACROCYCLIC METAL COMPLEXES FOR THEIR USE AS ANTICANCER AGENTS
#24Organic Compounds and their uses
#25Coating composition
#26CATHEPSIN CYSTEINE PROTEASE INHIBITORS
#27CLEAVAGE AGENT SELECTIVELY ACTING ON SOLUBLE ASSEMBLY OF AMYLOIDOGENIC PEPTIDE OR PROTEIN
#28Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads
#29MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS
#30Bridged aromatic substituted amine ligands with donor atoms
#31Antiviral indoles
#32MACROCYCLIC COMPOUNDS HAVING ASPARTIC PROTEASE INHIBITING ACTIVITY AND PHARMACEUTICAL USES THEREOF
#33Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof
#34Bridged aromatic substituted amine ligands with donor atoms
#35Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads